本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Cidara Therapeutics, Inc.

16.43
-1.3900-7.80%
盤後16.430.00000.00%16:05 EDT
成交量:11.95萬
成交額:197.43萬
市值:1.80億
市盈率:-0.61
高:17.20
開:17.20
低:16.10
收:17.82
資料載入中...
2022/03/07

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/07

重要事件披露

8-K - Current report
2022/03/07

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/04

重要事件披露

8-K - Current report
2022/02/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/14

重要事件披露

8-K - Current report
2021/11/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/15

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/15

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/21

重要事件披露

8-K - Current report
2021/09/01

重要事件披露

8-K - Current report
2021/08/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/17

重要事件披露

8-K - Current report
2021/08/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]